IMMUNOTOXINS IN THE THERAPY OF CANCER - FROM BENCH TO CLINIC

被引：38
作者：
GHETIE, V
VITETTA, E
机构：
[1] UNIV TEXAS, SW MED CTR, DEPT MICROBIOL, DALLAS, TX 75235 USA
[2] UNIV TEXAS, SW MED CTR, CTR CANC IMMUNOBIOL, DALLAS, TX 75235 USA
来源：
PHARMACOLOGY & THERAPEUTICS | 1994年 / 63卷 / 03期
关键词：
IMMUNOTOXIN; MONOCLONAL ANTIBODY; CANCER; THERAPY;
D O I：
10.1016/0163-7258(94)90025-6
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
This review presents only those contributions that have progressed from the bench to the clinic using murine monoclonal antibodies coupled chemically to toxins, their subunits or ribosome-inactivating proteins. The rationale and progress in the development, characterization, preclinical testing and clinical trials are discussed.
引用
收藏
页码：209 / 234
页数：26
相关论文
共 128 条
  • [31] FOON KA, 1984, BLOOD, V64, P1085
  • [32] IN-VIVO CD40-GP39 INTERACTIONS ARE ESSENTIAL FOR THYMUS-DEPENDENT HUMORAL IMMUNITY .2. PROLONGED SUPPRESSION OF THE HUMORAL IMMUNE-RESPONSE BY AN ANTIBODY TO THE LIGAND FOR CD40, GP39
    FOY, TM
    SHEPHERD, DM
    DURIE, FH
    ARUFFO, A
    LEDBETTER, JA
    NOELLE, RJ
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 178 (05) : 1567 - 1575
  • [33] FRANKEL AE, 1985, J BIOL RESP MODIF, V4, P273
  • [34] FULTON RJ, 1988, CANCER RES, V48, P2626
  • [35] GHETIE MA, 1992, BLOOD, V80, P2315
  • [36] DISSEMINATED OR LOCALIZED GROWTH OF A HUMAN B-CELL TUMOR (DAUDI) IN SCID MICE
    GHETIE, MA
    RICHARDSON, J
    TUCKER, T
    JONES, D
    UHR, JW
    VITETTA, ES
    [J]. INTERNATIONAL JOURNAL OF CANCER, 1990, 45 (03) : 481 - 485
  • [37] GHETIE MA, 1991, CANCER RES, V51, P5876
  • [38] GHETIE MA, 1994, BLOOD, V83, P1329
  • [39] GHETIE MA, 1988, CANCER RES, V48, P2610
  • [40] THE GLP LARGE-SCALE PREPARATION OF IMMUNOTOXINS CONTAINING DEGLYCOSYLATED RICIN-A CHAIN AND A HINDERED DISULFIDE BOND
    GHETIE, V
    THORPE, P
    GHETIE, MA
    KNOWLES, P
    UHR, JW
    VITETTA, ES
    [J]. JOURNAL OF IMMUNOLOGICAL METHODS, 1991, 142 (02) : 223 - 230
12345678910